A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma (Q40663897)

22 September 2017

title

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma (English)

1 reference

22 September 2017

0 references

0 references

Seiji Yamamoto

1

1 reference

22 September 2017

Tomoki Yamano

2

1 reference

22 September 2017

Maki Tanaka

3

1 reference

22 September 2017

Dave S B Hoon

4

1 reference

22 September 2017

Sonshin Takao

5

1 reference

22 September 2017

Ryuichi Morishita

6

1 reference

22 September 2017

Takashi Aikou

7

1 reference

22 September 2017

Yasufumi Kaneda

8

1 reference

22 September 2017

language of work or name

1 reference

1 March 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

179-186

1 reference

The basic science of gene therapy

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

De novo methylation and expression of retroviral genomes during mouse embryogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

The role of general initiation factors in transcription by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Gene therapy using HVJ-liposomes: the best of both worlds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Analysis of tumor growth curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Targeting chromatin disruption: Transcription regulators that acetylate histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Acetylation of general transcription factors by histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

What's up and down with histone deacetylation and transcription?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Histone deacetylase 1 can repress transcription by binding to Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Regulation of activity of the transcription factor GATA-1 by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Induction of MAGE-3 expression in lung and esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

inferred from DOI database lookup

7 January 2021

based on heuristic

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700551

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700551

1 reference

Dimensions Publication ID

22 September 2017

1046973678

0 references

1 reference